Skip to content

Liraglutide studies: 1,219 papers with results

Page 20 of 25

  1. Comparison of IBD-related outcomes in patients with obesity treated with GLP-1 receptor agonists versus bariatric surgery.

    Nanah MH · Crohn's & colitis 360 · 2026

    Not a test of Liraglutide alone · 44 results

  2. Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes.

    Kuhadiya ND · The Journal of clinical endocrinology and metabolism · 2016

    Not a test of Liraglutide alone · 10 results

  3. Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label, single-arm study.

    Seino Y · Journal of diabetes investigation · 2018

    Not a test of Liraglutide alone · 10 results

  4. Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis.

    Wang Y · The Journal of clinical endocrinology and metabolism · 2025

    Not a test of Liraglutide alone · 32 results

  5. The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial.

    Billings LK · Journal of diabetes science and technology · 2021

    Not a test of Liraglutide alone · 10 results

  6. Direct comparison two fixed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes.

    Risovic I · BMC endocrine disorders · 2023

    Not a test of Liraglutide alone · 10 results

  7. A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients.

    Abd El Aziz MS · Diabetes, obesity & metabolism · 2017

    Not a test of Liraglutide alone · 9 results

  8. Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis.

    Siskind D · Diabetes, obesity & metabolism · 2019

    Not a test of Liraglutide alone · 9 results

  9. Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetes.

    Kimura T · Molecular and cellular endocrinology · 2015

    Not a test of Liraglutide alone · 9 results

  10. Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study.

    Patel S · BMJ open diabetes research & care · 2019

    Not a test of Liraglutide alone · 9 results

  11. Glucagon-Like Peptide-1 Receptor Agonists Use Does Not Increase the Risk for Acute Pancreatitis and Is Associated With Lower Complications in Patients With Type 2 Diabetes Who Develop Acute Pancreatitis: A Multicenter Analysis.

    Nieto LM · The American journal of gastroenterology · 2026

    Not a test of Liraglutide alone · 36 results

  12. Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective.

    Shah D · ClinicoEconomics and outcomes research : CEOR · 2018

    Not a test of Liraglutide alone · 9 results

  13. A Retrospective Comparative Analysis of Cutaneous Adverse Reactions in GLP-1 Agonist Therapies.

    Daniel S · Journal of drugs in dermatology : JDD · 2025

    Not a test of Liraglutide alone · 27 results

  14. Efficacy of liraglutide on metabolic and reproductive outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis.

    Lu YT · Diabetes, obesity & metabolism · 2026

    Not a test of Liraglutide alone · 9 results

  15. Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes: The GRADE Randomized Clinical Trial.

    Luchsinger JA · JAMA internal medicine · 2025

    Not a test of Liraglutide alone · 9 results

  16. Association between eating behavior patterns and the therapeutic efficacy of GLP-1 receptor agonists in individuals with type 2 diabetes: a multicenter prospective observational study.

    Koide Y · Frontiers in clinical diabetes and healthcare · 2025

    Not a test of Liraglutide alone · 27 results

  17. Efficacy and safety of fixed-ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta-analysis of randomised controlled trials.

    Wang R · Diabetes/metabolism research and reviews · 2024

    Not a test of Liraglutide alone · 9 results

  18. Differential Longitudinal Effects of Glucose-Lowering Medications on Glucagon and C-peptide Responses in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).

    Kahn SE · Diabetes care · 2026

    Not a test of Liraglutide alone · 9 results

  19. Liraglutide enhances bone regeneration in a critical-size calvarial defect model in male rats: A comparative study with autogenous grafts, allografts, and xenografts.

    Zavrak N · Archives of oral biology · 2026

    Not a test of Liraglutide alone · 9 results

  20. Comparative analysis of IDegLira versus insulin glargine in short-term intensive therapy for overweight or obese patients with type 2 diabetes mellitus.

    Sun Y · Endocrine · 2026

    Not a test of Liraglutide alone · 9 results

  21. Influence of GLP-1 Receptor Agonists on Surgical and Nonsurgical Treatment of Ankle Osteoarthritis.

    Le Y · Foot & ankle specialist · 2026

    Not a test of Liraglutide alone · 27 results

  22. Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis.

    Ryan PM · The Journal of pediatrics · 2021

    Not a test of Liraglutide alone · 8 results

  23. Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add-on to sodium-glucose co-transporter-2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes.

    Philis-Tsimikas A · Diabetes, obesity & metabolism · 2019

    Not a test of Liraglutide alone · 8 results

  24. Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial.

    Harris SB · Diabetes, obesity & metabolism · 2017

    Not a test of Liraglutide alone · 8 results

  25. GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials.

    Tsapas A · Diabetes research and clinical practice · 2021

    Not a test of Liraglutide alone · 8 results

  26. Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece.

    Tzanetakos C · BMC health services research · 2014

    Not a test of Liraglutide alone · 12 results

  27. The efficacy and safety of liraglutide added to metformin in patients with diabetes: a meta-analysis of randomized controlled trials.

    Gu J · Scientific reports · 2016

    Not a test of Liraglutide alone · 8 results

  28. The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.

    Nowrouzi-Sohrabi P · European journal of pharmacology · 2021

    Not a test of Liraglutide alone · 8 results

  29. Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial.

    Lingvay I · Diabetes, obesity & metabolism · 2018

    Not a test of Liraglutide alone · 8 results

  30. Comparison of liraglutide plus basal insulin and basal-bolus insulin therapy (BBIT) for glycemic control, body weight stability, and treatment satisfaction in patients treated using BBIT for type 2 diabetes without severe insulin deficiency: A randomized prospective pilot study.

    Yamamoto S · Diabetes research and clinical practice · 2018

    Not a test of Liraglutide alone · 8 results

  31. Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2 diabetes.

    Sørensen KK · Cardiovascular diabetology · 2025

    Not a test of Liraglutide alone · 8 results

  32. Comparison of Efficacy and Safety of Commercially Available Fixed-Ratio Combinations of Insulin Degludec/Liraglutide and Insulin Glargine/Lixisenatide: A Network Meta-analysis.

    Visolyi GÁ · Canadian journal of diabetes · 2023

    Not a test of Liraglutide alone · 8 results

  33. Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Basal Insulin and Basal-Bolus Therapy in Patients with Type 2 Diabetes Based on Attainment of Clinically Relevant Treatment Targets.

    Cannon AJ · Journal of managed care & specialty pharmacy · 2020

    Not a test of Liraglutide alone · 8 results

  34. The Influence of GLP-1 Agonists on Human Mesenchymal Stem Cells: A Systematic Review.

    Weber L · Stem cell reviews and reports · 2026

    Not a test of Liraglutide alone · 8 results

  35. GLP-1 receptor agonists reduce body mass index and total daily insulin dose in youth with type 1 diabetes: a retrospective cohort study.

    Gonzalez F · Journal of pediatric endocrinology & metabolism : JPEM · 2026

    Not a test of Liraglutide alone · 24 results

  36. Incretin-Based Therapies for the Treatment of Binge Eating-A Systematic Review.

    White RT · Pharmacotherapy · 2026

    Not a test of Liraglutide alone · 16 results

  37. Liraglutide Plus Dapagliflozin for High Uric Acid and Microalbuminuria in Diabetes Mellitus Complicated With Metabolic Syndrome.

    Ou T · Alternative therapies in health and medicine · 2022

    Not a test of Liraglutide alone · 8 results

  38. GLP-1 receptor agonists in Parkinson's disease: a meta-analysis revealing motor benefit and highlighting mood improvement.

    Chen Y · Frontiers in neurology · 2026

    Not a test of Liraglutide alone · 8 results

  39. Relationship Between GLP-1-Based Therapies and Periodontal Health: A Systematic Review of Current Evidence and Future Perspectives.

    Nijakowski K · International journal of molecular sciences · 2026

    Not a test of Liraglutide alone · 8 results

  40. Weight Loss-Dependent Changes in Body Composition and Bone Health in People With Obesity and Type 1 Diabetes Treated With Liraglutide, Semaglutide, or Tirzepatide.

    Al Ozairi E · Diabetes/metabolism research and reviews · 2026

    Not a test of Liraglutide alone · 24 results

  41. Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial.

    Billings LK · Diabetes care · 2018

    Not a test of Liraglutide alone · 7 results

  42. The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials.

    Austregésilo de Athayde De Hollanda Morais B · Journal of diabetes and its complications · 2024

    Not a test of Liraglutide alone · 14 results

  43. Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetes.

    Meiring S · American journal of physiology. Endocrinology and metabolism · 2022

    Not a test of Liraglutide alone · 7 results

  44. Long-term Cost-effectiveness of Two GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus in the Italian Setting: Liraglutide Versus Lixisenatide.

    Hunt B · Clinical therapeutics · 2017

    Not a test of Liraglutide alone · 7 results

  45. A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-like peptide-1 receptor agonist plus basal insulin: The SIMPLE study.

    Abreu M · Diabetes, obesity & metabolism · 2019

    Not a test of Liraglutide alone · 7 results

  46. Cardioprotective properties of glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus patients: A systematic review.

    Widiarti W · Diabetes & metabolic syndrome · 2021

    Not a test of Liraglutide alone · 7 results

  47. A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice.

    Sesti G · Diabetes, obesity & metabolism · 2020

    Not a test of Liraglutide alone · 7 results

  48. Effects of glucagon-like peptide-1 receptor agonists on male reproductive hormones, semen parameters, and metabolic outcomes: a systematic review.

    Deameh MG · The journal of sexual medicine · 2026

    Not a test of Liraglutide alone · 14 results

  49. IDegLira for the real-world treatment of type 2 diabetes in Italy. Final results from the REX observational study.

    Fadini GP · Diabetes, obesity & metabolism · 2024

    Not a test of Liraglutide alone · 7 results

  50. The effects of glucagon-like peptide-1 receptor agonists (GLP1-RAs) on alcohol-related outcomes: a systematic review and meta-analysis.

    Sinha B · Addiction science & clinical practice · 2025

    Not a test of Liraglutide alone · 16 results

How PepBank reports evidence